Menu

PROGRAM - (subject to change)
Friday, January 17th

7:30-8:30am

Registration/Visit Exhibits

7:45-8:30am

Clinical Vignettes: How Do the Experts Make Decisions
Barry Greenberg MD (Moderator)
   Case 1. Anya Narezkina MD
   Case 2. Nicolas Wettersten, MD
   Case 3. Barry Greenberg, MD
Please note: This session is Non-CME and will not be live streamed.

8:30-9:30am

Product Theatre I - Breakfast Served - Non-CME
Aldosterone Dysregulation: Cardiovascular and Renal Implications
Vladimir Yurukov PharmD BCPS, APh and Vicky Kuo, PharmD
Supported by: AstraZeneca

9:40am

Welcome and Introduction to the Symposium
Barry Greenberg, MD

SESSION I - Patients and Populations at Risk for Developing Heart Failure
Pam Taub, MD (Moderator)

9:50-10:10am

Identifying Patients at Risk for Developing Heart Failure
Pam Taub, MD

10:10-10:30

Using SGLT inhibitors to Prevent CV Disease and Heart Failure
Jia Shen, MD

10:30-10:50

FEATURED LECTURE I
GLP-1 Agonists for Reducing Weight, Preventing CV Disease and Treating Heart Failure
Athena Philis-Tsimikas, MD

10:50-11:10

Identifying and Treating Patients with Dyslipidemia
Michael Wilkinson, MD

11:10-11:30

Use of Non-Steroidal MRAs To Prevent CV Disease, CKD and Heart Failure
Nick Wettersten, MD

11:30-11:50

Identifying Patients at Risk for Cardiac Toxicity from Chemotherapy - Update on How to Monitor and Preventive Strategies
Anya Narezkina, MD

11:50-12:00

What Do Patients Want to Know About Preventing Cardiovascular Disease
Patient Advocate

12:00-12:25pm

Reducing Cardiovascular Risk in Our Patients: Case Presentation and Panel Discussion
Pam Taub, MD (Moderator)
Drs. Shen, Tsimikas, Wettersten, Narezkina, Andrew Williford PharmD and Patient Advocate (Panelists)

12:25-12:40

Visit Exhibits

12:40-1:40

Product Theatre II - Lunch Served - Non-CME
Discover AMVUTTRA® (vutrisiran): A Treatment Option for the Polyneuropathy of hATTR Amyloidosis
Marcus Anthony Urey, MD
Supported by: Alnylam Pharmaceuticals, Inc.

1:40-1:55

Visit Exhibits

SESSION II - Amyloidosis, Infiltrative Heart Disease, Hypertrophic Cardiomyopathy and Mongenic Cardiomyopathies
Marcus Anthony (Tony) Urey, MD (Moderator)

1:55-2:15

FEATURED LECTURE II
Recognizing and Treating Patients with Amyloidosis
Marcus Anthony (Tony) Urey, MD

2:15-2:35

Cardiac Myosin Inhibitors and Other New Treatment Options for Patients with Hypertrophic Cardiomyopathy
Jorge Silva Enciso, MD

2:35-2:55

Identifying and Treating Sarcoidosis and Other Infiltrative Diseases That Cause Heart Failure
Kimberly Hong, MD

2:55-3:10

Refreshment Break/Visit Exhibits

3:10-3:30

Gene Therapy for Monogenic Causes of Heart Failure and Other Cardiovascular Diseases
Barry Greenberg, MD

3:30-3:50

Pulmonary Arterial Hypertension (PAH)
Demosthenes Papamatheakis, MD

3:50-4:10

FEATURED LECTURE III
Heart Failure Management in Adult Congenital Heart Disease
Laith Alshawabkeh, MD

4:10-4:30

Peripartum Cardiomyopathy
Uri Elkayam, MD

4:30-4:50

Case Presentation and Panel Discussion
Marcus Anthony (Tony) Urey (Presentor)
Drs. Silva, Hong, Greenberg, Papamatheakis, Alshawabkeh, Elkayam, Jade Kozach PharmD (Discussants)

4:50

Adjourn Day 1


Saturday, January 18th

7:15-7:30am

Registration/Visit Exhibits

7:30am

Coffee and Master Class on Physical Diagnosis
Barry Greenberg, MD

8:00-9:00

Product Theatre III - Breakfast Served - Non-CME
Wainua: hATTR Progression: Addressing Polyneuropathy
Marcus Anthony Urey, MD
Supported by: AstraZeneca

9:00-9:15

Visit Exhibits

9:15

Welcome and Introduction to Day 2 of the Symposium
Barry Greenberg, MD

SESSION III - Identifying and Treating Heart Failure
Barry Greenberg, MD (Moderator)

9:15-9:30

Monitoring Devices To Identify and Treat Congestion
Hao (Howie) Tran, MD

9:30-9:45

Treating Patients with HFrEF-The Four Pillars of Therapy
Gregg Fonarow, MD

9:45-10:00

Implementing GDMT for Heart Failure-What’s the Best Approach?
Gregg Fonarow, MD

10:00-10:15

Adjunctive Medical Therapy for Treating Patients with HFrEF
Uri Elkayam, MD

10:15-10:35

Treating Patients with HFpEF – How Do the Experts Do It?
J. Thomas Heywood, MD

10:35-10:50

Coffee Break/Visit Exhibits

10:50-11:05

Using Biomarkers To Identify and Manage Heart Failure
Lori Daniels, MD

11:05-11:20

Novel Approaches for Recognizing and Treating Congestion
Antoinette Birs, MD

11:20-11:35

FEATURED LECTURE IV
How to Talk So Patients Will Listen/How to Listen So Patients Will Talk
Julia McCain, PA and Trina Huynh, PharmD

11:35-11:45

Living with Heart Failure: A Patient’s Perspective
Patient Advocate

11:45-12:10

Case Presentation
Barry Greenberg, MD (Moderator)
Drs. Fonarow, Tran, Elkayam, Daniels, Birs, Heywood and Julia McCain, PA, Trina Huynh PharmD and Patient Advocate (Panelists)

12:10-12:25pm

Visit Exhibits

12:25-1:25

Product Theatre IV - Lunch Served - Non-CME
Symptomatic Obstructive Hypertrophic Cardiomyopathy: A review of the phase 3 data and ongoing long-term extension trials with the first and only approved cardiac myosin inhibitor for adults with oHCM
Jorge Silva Enciso, MD
Supported by: Bristol-Myers Squibb

1:25-1:40

Visit Exhibits

SESSION IV - Cardiogenic Shock, Percutaneous Devices to Support Cardiac Function, Strategies for Preventing Sudden Cardiac Death and Catheter Based Treatment of Atrial Fibrillation and Valvular Disease
Lori Daniels, MD (Moderator)

1:40-2:00

Identifying and Treating Cardiogenic Shock
Lori Daniels, MD

2:00-2:20

Percutaneous Devices for Temporary Support of Cardiac Function
Howie Tran, MD

2:20-2:40 

Catheter Based Treatments of Valvular Heart Disease
Matthew Price, MD

2:40-3:00

Left Atrial Occlusion Devices for Preventing Thromboemboli Complications of Atrial Fibrillation
Jonathan Hsu, MD

3:00-3:10

Coffee Break/Visit Exhibits

SESSION V - Emerging Strategies for Detecting and Treating Sudden Cardiac Death and Advanced Heart Failure
Hao (Howie) Tran, MD (Moderator)

3:10-3:30

Advances in Preventing Sudden Cardiac Death in Patients with Heart Failure
David Krummen, MD

3:30-3:50

FEATURED LECTURE V
Stage D Heart Failure and Available Treatment Options to Improve Outcomes
Ben Cruz, MD

3:50-4:10

Palliative and Hospice Care for Patients with Advanced Heart Failure
Eric Adler, MD

4:10-4:20

Treatment Options for Advanced Heart Failure: A Patient’s Perspective
Patient Advocate

4:20-4:45

Case Presentation and Panel Discussion
Hao (Howie) Tran, MD (Moderator)
Drs. Krummen, Hsu, Price, Shapiro, Adler and Melissa McLenon, NP, Trina Huynh PharmD and Patient Advocate (Panelists)

4:45

Adjourn